🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Vaxcyte, Inc.

PCVX Healthcare
$63.3 +$3.51 (5.87%)
Market Cap: $9.42 B
Gurus Holding
4
Popularity Rank
#2281
% of Shares Held
1.15%
Net Activity (Q2 2026)
-$68.19 M

Guru Ownership Trend

Guru Analysis for Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. (PCVX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $108.73 M.

Top institutional holders include Lee Ainslie and Ray Dalio.

Institutional sentiment is currently Bearish. This is evidenced by a $68.19 M net outflow during the quarter.

Recent activity highlights Ray Dalio who increased their stake by 289.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 64.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$16.39 M
Total Buy Value
New Buys 0
Additions 3
-$84.58 M
Total Sell Value
Reductions 1
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
3

FAQs for Vaxcyte, Inc. (PCVX)

Major holders include Lee Ainslie ($93.78 M), Ray Dalio ($2.92 M), Cliff Asness ($2.01 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.72 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $68.19 M, with 3 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited PCVX. The total reported sell value was $84.58 M.

Yes, 0 managers opened new positions in PCVX, and 3 increased their existing holdings. The total reported buy value was $16.39 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.83% Add 17.1% 1,613,242 $93.78 M Q2 2026
0.01% Add 289.2% 50,217 $2.92 M Q2 2026
0.00% Add 35.8% 34,563 $2.01 M Q2 2026
0.00% Reduce -64.1% 19,634 $1.14 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form